Immunic Inc. – Filings and Transcripts

NASDAQ: IMUX
Share price (11/6/26): $7.75
Market cap (11/6/26): $106 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Shelf registration – amended

Registration of securities for employees

Shelf registration

Ownership Filter

Aberdeen Group Plc

Nagel Robert Thorvald

Biotechnology Value Fund L P, Bvf Partners L P/Il, Bvf Inc/Il, Biotechnology Value Fund II LP, Lampert Mark N, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., Bvf I GP LLC, Bvf II GP LLC, Bvf GP Holdings LLC

Commodore Capital LP

Nantahala Capital Management, LLC

News Filter

Material Disclosure, Financial Statements or Exhibits

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Material Disclosure, Financial Statements or Exhibits

Appoints Elena Ridloff to Board of Directors

Material Disclosure, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC